Shoulder / Rotator Cuff Tendinopathy / PRP+HA / VAS+QuickDASH

This Circle helps physicians capture and monetize real-world data from their everyday delivery of PRP and Hyaluronic Acid (HA) for Rotator Cuff Tendinopathy.

The Platelet Rich Plasma “PRP” Market is valued at 828.8 Billion in 2023, and is estimated to grow to over 3 Trillion by 2032. The HA Market is currently estimated at 11.14 Billion (2025) and predicted to grow to about 19.94 Billion by 2034. The prevalence of Rotator Cuff Tendinopathy is around 5% to 10% among the general population. The condition becomes more prevalent with age, particularly in individuals over 40 years old. Manufacturers will thus increasingly spend on obtaining and maintaining regulatory approvals for marketing those products for Rotator Cuff Tendinopathy. Increasingly, that spending will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Rotator Cuff Tendinopathy cases, outcomes and other case data.